Jasper Therapeutics Inc. (JSPR)
6.04
0.11 (1.85%)
At close: Mar 03, 2025, 12:23 PM
Jasper Therapeutics Balance Sheet Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 |
Cash & Equivalents | 71.64M | 86.89M | 38.25M | 84.7M | 19.84M | 27.16M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | 100.15M |
Long-Term Investments | n/a | n/a | 417K | 345K | 345K | n/a |
Other Long-Term Assets | 1.24M | 1.76M | 1.18M | 990K | 643K | 48K |
Receivables | n/a | 250K | n/a | n/a | 600K | n/a |
Inventory | n/a | n/a | n/a | -548K | 95.47K | n/a |
Other Current Assets | 4.17M | 1.8M | 3.48M | 3.13M | 43K | n/a |
Total Current Assets | 75.81M | 88.94M | 41.73M | 87.83M | 20.68M | 27.16M |
Property-Plant & Equipment | 2.85M | 4.19M | 5.45M | 4.83M | 2.03M | n/a |
Goodwill & Intangibles | n/a | n/a | -980K | -668K | -744K | n/a |
Total Long-Term Assets | 4.09M | 5.95M | 6.63M | 5.82M | 2.67M | 48K |
Total Assets | 79.9M | 94.89M | 48.36M | 93.65M | 23.36M | 27.21M |
Account Payables | 4.03M | 4.15M | 1.77M | 3.92M | 1.42M | 623K |
Deferred Revenue | n/a | n/a | n/a | 2.81M | n/a | n/a |
Short-Term Debt | 1.09M | 972K | 1.73M | 1.01M | n/a | n/a |
Other Current Liabilities | 10.12M | 7.25M | 3.57M | 3.09M | 2.59M | 1.37M |
Total Current Liabilities | 15.24M | 12.37M | 7.07M | 8.02M | 4.01M | 1.99M |
Long-Term Debt | 724K | 1.81M | 2.79M | 2.38M | 1.62M | n/a |
Other Long-Term Liabilities | 2.26M | 2.26M | 2.52M | 13.74M | 52.85M | n/a |
Total Long-Term Liabilities | 2.99M | 4.08M | 5.31M | 16.12M | 54.48M | n/a |
Total Liabilities | 18.23M | 16.45M | 12.37M | 24.14M | 58.49M | 1.99M |
Total Debt | 1.81M | 2.79M | 3.65M | 2.88M | 1.62M | n/a |
Common Stock | 2K | 1K | 4K | 4K | 1K | 10K |
Retained Earnings | -240.87M | -169.6M | -105.14M | -67.45M | -36.81M | -5.14M |
Comprehensive Income | n/a | n/a | 0.00 | -93.65M | -43.84M | n/a |
Shareholders Equity | 61.67M | 78.44M | 35.99M | 69.52M | -35.13M | 21.1M |
Total Investments | n/a | 417K | 417K | 345K | 345K | 100.15M |